Established in 1958, Edwards Lifesciences (EW)is an acknowledged leader in production of technologies for heart disease treatment. The company’s headquarters are based in Irvine, California. Apart from heart valve treatment, the company specialises in vascular therapy, surgical monitoring, critical care services. Edwards Lifesciences employs 12,000 people worldwide. The company’s shares are quoted on the New York Stock Exchange (NYSE). To stay updated on the latest Edwards Lifesciences share price, follow Capital.com.
Latest shares articles
Alibaba price forecast: Third-party price targets
Read our Alibaba price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:15, 30 April 2025
Amazon Q1 Preview: AI Ambitions Under Scrutiny Amid Trade Policy Headwinds and Margin Pressures
Amazon (AMZN) is set to report its Q1 2025 results after the close on May 1, with investors closely watching how the e-commerce and cloud giant is navigating a more challenging macroeconomic environment.
10:01, 30 April 2025
Apple Q2 Earnings Preview: US trade policy risks profit margins and China sales
Apple (AAPL) is scheduled to report its fiscal second-quarter (Q2 FY2025) results after the close on May 1, with investors weighing slowing demand trends against renewed geopolitical risks, notably the reemergence of US-China trade tensions.
14:33, 29 April 2025
Meta set to report Q1 earnings as ad-pricing headwinds test growth outlook
Meta Platforms (META) is scheduled to report its fiscal first-quarter earnings after the market closes on April 30. The social media giant heads into the results under pressure to maintain its growth trajectory amid emerging ad-pricing challenges and a softening macroeconomic environment.
09:22, 29 April 2025
Ratings and Reviews
Ratings and Reviews
